ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence
NCT ID: NCT05301673
Last Updated: 2024-12-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
600 participants
OBSERVATIONAL
2022-07-12
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
ART-CARMA benefits from the ADHD Remote Technology ('ART') assessment and monitoring system for adults with ADHD (developed by Kuntsi, Dobson, et al.), and the RADAR-base mobile-health platform to which it is linked (developed by Dobson et al; http://www.radar-base.org). ART consists of both active (e.g., questionnaires) and passive (smartphone and a wearable device) monitoring. ART-CARMA will use remote measurement technology (RMT) in adults with ADHD to carry out unobtrusive, real-time data collection over a continuous period of 12 months. By recruiting 300 adults from adult ADHD clinic waiting lists (and a partner/family member/close friend for each of them) and monitoring them remotely, we will obtain objectively measured data relevant to cardiometabolic risk profiles from their daily lives. By targeting the period before starting any ADHD medication through to starting treatment and the subsequent period, up to 12 months in total, we obtain real-time data on multiple parameters, including side effects, that can inform the personalisation of treatment.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adults with ADHD
No interventions assigned to this group
Partner, family member or close friend of the individuals with ADHD
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-60
* Able to give informed consent for participation
* Fluent in English
* Willing and able to complete self-reported assessments via smartphone
* Willing to use either their own compatible Android phone or a study Android phone as their only smartphone during the data collection period
* Willing to wear the wearable device (EmbracePlus) during the data collection period
* Not on ADHD medication at the time of recruitment
Exclusion Criteria
* Recent contact with psychiatric acute care (admission, crisis team or liaison team (A\&E)) in the last six months
* Any other major medical disease which might impact upon the patient's ability to participate in normal daily activities (e.g., due to hospitalisations)
* Pregnancy
* IQ \< 70
* Does not start ADHD medication following ADHD diagnosis (either due to personal choice or psychiatrist deciding not to prescribe ADHD medication)
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South London and Maudsley NHS Foundation Trust
OTHER
Barnet, Enfield and Haringey Mental Health NHS Trust
OTHER_GOV
Hospital Universitari Vall d'Hebron Research Institute
OTHER
Empatica, Inc.
INDUSTRY
Örebro University, Sweden
OTHER
Concentris research management gmbh
UNKNOWN
Attention Deficit Disorder Information and Support Service
UNKNOWN
The European Association for the Study of Obesity
UNKNOWN
Northumberland, Tyne and Wear NHS Foundation Trust
OTHER
Tees, Esk and Wear Valleys NHS Foundation Trust
UNKNOWN
South West London and St George's Mental Health NHS Trust
OTHER
East London NHS Foundation Trust
OTHER_GOV
Avon and Wiltshire Mental Health Partnership NHS Trust
OTHER_GOV
King's College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonna Kuntsi, BSc, MSc, PhD
Role: PRINCIPAL_INVESTIGATOR
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vall d'Hebron Research Institute
Barcelona, , Spain
King's College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
304278
Identifier Type: -
Identifier Source: org_study_id